When we think of the word “antioxidant," we often associate it with health and vitality. Fruits and vegetables “rich in antioxidants" are a good thing after all, right? A new study conducted in mice, however, suggests that antioxidants can actually double the rate of melanoma metastasis.
Publications
FDA Approves Combination Therapy For BRAF Wild-Type Unresectable or Metastatic Melanoma
Bristol-Myers Squibb recently announced the approval by the U.S. Food and Drug Administration (FDA) of its combination therapy, Opdivo (nivolumab) with Yervoy (ipilimumab), for BRAF V600 wild-type unresectable or metastatic melanoma. This is the first combination therapy of two immuno-oncology drugs approved by the FDA.
Antioxidants Facilitate Melanoma Metastasis
Two compounds boost the ability of melanoma cells to invade other tissues in mice, providing additional evidence that antioxidants can be beneficial to malignant cells as well as healthy ones
Nab-Paclitaxel Shows Benefit in Advanced Melanoma
Treatment with nab-paclitaxel resulted in significantly improved progression-free survival and a greater disease control rate in chemotherapy-naive patients with metastatic melanoma compared with dacarbazine, according to the results of a study published recently in Annals of Oncology.